The Rose Room Limited 11000814 false 2024-11-01 2025-10-31 2025-10-31 The principal activity of the company is providing health treatments such as Botox, laser hair removal, tattoo removal and teeth whitening. Digita Accounts Production Advanced 6.30.9574.0 true 11000814 2024-11-01 2025-10-31 11000814 2025-10-31 11000814 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 11000814 core:Non-currentFinancialInstruments core:AfterOneYear 2025-10-31 11000814 bus:Micro-entities 2024-11-01 2025-10-31 11000814 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 11000814 bus:FilletedAccounts 2024-11-01 2025-10-31 11000814 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 11000814 bus:RegisteredOffice 2024-11-01 2025-10-31 11000814 bus:Director1 2024-11-01 2025-10-31 11000814 bus:Director2 2024-11-01 2025-10-31 11000814 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 11000814 bus:Agent1 2024-11-01 2025-10-31 11000814 countries:EnglandWales 2024-11-01 2025-10-31 11000814 2023-11-01 2024-10-31 11000814 2024-10-31 11000814 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 11000814 core:Non-currentFinancialInstruments core:AfterOneYear 2024-10-31 iso4217:GBP xbrli:pure

Registration number: 11000814

The Rose Room Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 October 2025

 

The Rose Room Limited

Contents

Company Information

1

Statement of Financial Position

2 to 3

 

The Rose Room Limited

Company Information

Directors

R L M Ransome

C Ransome

Registered office

Salatin House
19 Cedar Road
Sutton
Surrey
SM2 5DA

Accountants

Shaw Gibbs Limited Salatin House
19 Cedar Road
Sutton
Surrey
SM2 5DA

 

The Rose Room Limited

(Registration number: 11000814)
Statement of Financial Position as at 31 October 2025

Note

2025
£

2024
£

Fixed assets

424

1,656

Current assets

12,574

9,713

Prepayments and accrued income

698

698

Payables: Amounts falling due within one year

(8,246)

(12,776)

Net current assets/(liabilities)

 

5,026

(2,365)

Total assets less current liabilities

 

5,450

(709)

Payables: Amounts falling due after more than one year

(25,000)

(25,000)

Accruals and deferred income

(2,292)

(2,088)

   

(21,842)

(27,797)

Capital and reserves

(21,842)

(27,797)

1

General information

The Rose Room Limited (the 'company') is a private company limited by share capital, registered in England and Wales under the Companies Act. The address of the registered office is given on page 1. The nature of the company’s operations and its principal activities are set out in the directors' report on page 2.

2

Staff numbers

The average number of persons employed by the company during the year, was 2 (2024 - 2).

3

Basis of preparation

The financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.

 

The Rose Room Limited

(Registration number: 11000814)
Statement of Financial Position as at 31 October 2025 (continued)

For the financial year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Income Statement has been taken.

The directors of the company have elected not to include a copy of the income statement within the financial statements.

The financial statements of The Rose Room Limited were approved and authorised for issue by the Board on 26 June 2026 and signed on its behalf by:
 

.........................................

R L M Ransome
Director